Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193805-24-000089
Filing Date
2024-01-24
Accepted
2024-01-24 17:05:15
Documents
3
Period of Report
2024-03-04

Document Format Files

Seq Description Document Type Size
1 e619200_pre14a-immunic.htm PRE 14A 635814
2 GRAPHIC image_001.jpg GRAPHIC 6573
3 GRAPHIC image_002.jpg GRAPHIC 5923
  Complete submission text file 0001193805-24-000089.txt   654477
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36201 | Film No.: 24557403
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)